cytarabine has been researched along with Adenoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, T; Kakihara, T; Kamishima, T; Matsumoto, K; Suzuki, T; Uchiyama, M; Yamada, T | 1 |
Gala, I; Kim, YN; Moster, M; Pleanboonlers, N; Rerkpattanapipat, P; Suwattee, P; Turtz, A; Wongpraparut, N | 1 |
Shimkin, MB; Stoner, GD; Theiss, JC | 1 |
3 other study(ies) available for cytarabine and Adenoma
Article | Year |
---|---|
Reactivity of antibody YU-311 in formalin-fixed, paraffin-embedded specimens of normal organs, non-hematopoietic tumors, and mast cell tumors.
Topics: Adenoma; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Antimetabolites, Antineoplastic; Carcinoma; Cytarabine; Drug Resistance, Neoplasm; Humans; Immunohistochemistry; Mast-Cell Sarcoma; Paraffin Embedding | 1997 |
Pituitary apoplexy in a patient with acute myeloid leukemia and thrombocytopenia.
Topics: Adenoma; Aged; Antimetabolites, Antineoplastic; Cytarabine; Female; Humans; Leukemia, Monocytic, Acute; Magnetic Resonance Imaging; Pituitary Apoplexy; Pituitary Gland; Pituitary Neoplasms; Radiography; Thrombocytopenia | 2000 |
Murine pulmonary adenoma bioassay of potentially effective agents against slow-growing solid tumors.
Topics: Adenoma; Animals; Antineoplastic Agents; Cell Division; Cell Survival; Cells, Cultured; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Female; Humans; Hydroxyurea; Lung Neoplasms; Male; Mice; Mice, Inbred A; Neoplasms, Experimental; Urethane | 1977 |